ErkutHasanBorazanciMDMS

PubMed

• 134 citations
  Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions
  Wei Lin, Pawan Noel, Erkut Borazanci, Jeeyun Lee, Albert Amini
  Genome Medicine. 2020-09-29
• 141 citations
  Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic...
  Dung T. Le, Vincent J. Picozzi, Andrew H. Ko, Zev A. Wainberg, Hedy L. Kindler
  Clinical Cancer Research. 2019-09-15
• 49 citations
  An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.
  Kota Nakamura, Zhongxu Zhu, Souvick Roy, Eunsung Jun, Haiyong Han
  Gastroenterology. 2022-11-01

Journal Articles

• Ask ACCC’s Community Resource Centers: Pancreatic adenocarcinoma  
  Borazanci, E, Oncology, 1/1/2014

Abstracts/Posters

• Preliminary activity in the first in human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640
  Emma Jane Dean, Gerald Steven Falchook, Manish R. Patel, Andrew Jacob Brenner, Jeffrey R. Infante, Hendrik-Tobias Arkenau, Erkut Hasan Borazanci, Juanita Suzanne Lopez..., J Clin Oncol, 1/1/2016
• Phase 1b study of aldoxorubicin + gemcitabine in metastatic solid tumors.
  Kamalesh Kumar Sankhala, Shanta Chawla, Victoria S. Chua, Jasgit C. Sachdev, Erkut Hasan Borazanci, Kelli Sung, Monica M. Mita, Alain C. Mita, Brenda Laabs, Scott Wiel..., J Clin Oncol, 1/1/2016
• First-in-human phase 1 dose-escalation study of DS-6051b, an oral ROS1 and NTRK inhibitor, in subjects with advanced solid tumors.
  Kyriakos P. Papadopoulos, Erkut Borazanci, Daniel Von Hoff, Leena Gandhi, Amita Patnaik, Masaya Tachibana, Hamim Zahir, Roohi Gajee, Terri Goldberg, Giorgio Senaldi, S..., AACR, New Orleans, LA, 1/1/2016
• Adenosquamous Carcinoma of the Pancreas: molecular characterization of 23 patients along with a literature review. Submitted for publication.
  Borazanci E, Millis S, Korn R, Han H, Whatcott CJ, Gatalica Z, Barrett MT, D Cridebring D, and Von Hoff MD., World Journal of Gastronintestinal Oncology, 1/1/2015
• A retrospective analysis assessing effects of cytotoxic versus cytostatic agents on body mass, nutritional parameters, and performance status in patients with exocrine...
  Schwerkoske JP, Borazanci E, Schroeder K, Zhang L, Jameson GS, Schaffer JR, Nieves JA, and Von Hoff DD., GI ASCO 2015 Meeting. J Clin Oncol, 1/1/2015
• Detection of potential actionable targets in appendiceal cancer detected by immunohistochemistry (IHC), fluorescent in situ hybridization (FISH), and mutational analysis
  Borazanci E, Kimbrough J, Sachdev JC, Millis SZ, Ejadi S, Burnett K, Ratliff S, Von Hoff DD, Ramanathan RK, GI ASCO 2014 Meeting. J Clin Oncol, 1/1/2014
• Reinitiating nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer.
  Borazanci E, Schroeder K, Jameson G, Ramanathan R, and Von Hoff DD, GI ASCO 2014 Meeting. J Clin Oncol, 1/1/2014
• Potential actionable targets in appendiceal cancer detected by immunohistochemistry (IHC), fluorescent in situ hybridization (FISH), and mutational analysis. Poster pr...
  Borazanci E, Millis SZ, Feldman RA, Ghazalpour A, Von Hoff DD, Ramanathan RK., ASCO Meeting. J Clin Oncol, 1/1/2014
• Nab-paclitaxel and Gemcitabine for the treatment of patients with metastatic pancreatic cancer.
  Borazanci E and Von Hoff DD., Expert Review of Gastroenterology & Hepatology, 1/1/2014
• Association of core-binding factor Beta with the malignant phenotype of prostate and ovarian cancer cells.
  Davis JN, Rogers D, Adams L, Yong T, Jung JS, Cheng B, Fennell K, Borazanci E, Moustafa YW, Sun A, Shi R, Glass J, Mathis JM, Williams BJ, Meyers S., J Cell Physiol., 1/1/2010
• RUNX Expression profiling abstract.
  Piper VG, LSUHSC-S Barlow Symposium, Shreveport, LA, 1/1/2004
• Phase I Dose Escalation and Pharmokinetic Study of 14-O-phosphonooxymethyltriptolide.
  Edward Greeno, Erkut Borazanci, Jon Gockerman, Ronald Korn, Ashok Saluja, Daniel Von Hoff., AACR 2015 Annual Meeting, Philadelphia, PA, 1/18/2015
• RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
  Fowler, M, Borazanci E, McGhee L, Pylant SW, Williams BJ, Glass J, Davis JN, Meyers S., J Cell Biochem, 1/1./2006
• Prognosis of baseline absolute lymphocyte count (ALC) and neutrophil to lymphocyte ratio (NLR) in patients with pancreatic adenocarcinoma.
  Sachin Pai, Kartik Anand, Erkut Borazanci, Runhua Shi, Syed H Jafri, and Glenn Mills., Louisiana Cancer Research Consortium Scientific Retreat, New Orleans, LA, 1/10/2015
• High complete and partial response rate in a phase Ib pilot trial with albumin-bound paclitaxel and gemcitabine plus cisplatin in patients with advanced pancreatic cancer
  Jameson GS, Borazanci E, Poplin E, Barrett MT, Crowley J, Rosenthal A, Stoll -D’Astice A, Ansaldo K, Boone S, Lebron L, Ramanathan RK, Korn R, Von Hoff DD., AACR 2015 Annual Meeting, Philadelphia, PA, 1/18/2015
• Evaluating high risk BI-RADS 4 mammographic lesions: a pilot trial of textural analysis (TA) as a supplement to digital mammography (DM)
  Melissa R Gordon, Erkut Borazanci, Daniel D Maki, and Ronald Korn., AACR 2015 Annual Meeting, Philadelphia, PA, 1/18/2015
• Prognosis of baseline absolute lymphocyte count (ALC) and neutrophil to lymphocyte ratio (NLR) in patients with pancreatic adenocarcinoma.
  Kartik Anand, Sachin Pai, Erkut Borazanci, Runhua Shi, Syed H Jafri, and Glenn Mills., AACR 2015 Annual Meeting, Philadelphia, PA, 1/18/2015
• Ibrutinib in combination with durvalumab (MEDI4736) in patients with relapsed or refractory HER2-positive or triple-negative breast cancer: A phase 1b/2 multicenter st...
  Drew W. Rasco, Erkut Borazanci, Martin Guiterrez, David Hong, Ahmed Tawash, Jennifer Lin, Isaiah W. Dimery, Mark Fosdale, AACR Advances in Breast Cancer Research, Bellevue, WA
• A First-In-Human Study of the First-In-Class Fatty Acid Synthase (FASN) Inhibitor TVB-2640 Results of Dose Escalation in Mono and Combination and Evidence of Prelimina...
  A. Brenner, J. Infante, M. Patel, HT. Arkenau, M. Voskoboynik , E. Borazanci, G. Falchook , L.R. Molife , S. Pant , E. Dean ,L. Pelosof , S. Jones, C. Rubino , W. McCu..., AACR-NCI-EORTC 2015 meeting, 1/6./2015
• Phase I dose escalation and pharmokinetic study of a modified schedule of 14-o-phosphonooxymethyltriptolide.
  Edward Greeno, Erkut Hasan Borazanci, Jon P. Gockerman, Ronald Lee Korn, Ashok Saluja, Daniel D. VonHof., J Clin Oncol, Gastrointestinal Cancers Symposium, San Francisco, 1/21/2016
• Ibrutinib + durvalumab (MEDI4736) in patients (pts) with relapsed or refractory (R/R) pancreatic adenocarcinoma (PAC): A phase Ib/II multicenter study.
  Erkut Hasan Borazanci, David S. Hong, Martin Gutierrez, Drew W. Rasco, Tony R. Reid, Michael H. Veeder, Ahmed Tawashi, Jennifer Lin, Isaiah W. Dimery., J Clin Oncol, Gastrointestinal Cancers Symposium, San Francisco, 1/21/2016
• Improving Pancreatic Cancer Risk Prediction through Early Detection.
  Courtney Snyder, Susan G. Haag, Nickie Adams, Jade Hess, Breann Paskett, and Erkut H. Borazanci., AACR Conference: Improving Cancer Risk Prediction for Prevention and Early Detection, 1/16/2016
• Join now to see all

Lectures

• A phase I dose-escalation and immune biomarker study of intravenous FF-10832, liposomal gemcitabine, in patients with advanced solid tumors. 
  2019 ASCO Annual Meeting - 6/1/2019
• A Pilot, Phase II study in patients treated with MM-398, nanoliposomal irinotecan (nal-IRI) using Ferumoxytol (FMX) contrast MRI as a biomarker to predict patient resp... 
  1/1/2014
• Foreign Body Ingestion-presented to LSUHSC-S pediatric students and pediatric staff. 
  Shreveport, LA - 1/1/2007
• Thesis defense, RUNX Expression Profiling in Human Cell Lines and Tissue 
  LSUHSC-S Department of Biochemistry and Molecular Biology. Shreveport, LA - 1/1/2004
• Cancer Genomics. 
  Shreveport, LA. - 1/11/2013
• Vitamin D Deficiency 
  Shreveport, LA - 1/5./2008
• Morbidity and Mortality Case presentation 
  Overton Brooks VA Medical Center Internal Medicine. Shreveport, LA - 1/22/2009
• Cirrhosis secondary to NASH 
  Shreveport, LA - 1/15/2010
• Dyslipidemia 
  Shreveport, LA. - 1/1./2010
• Bisphosphonates and Atypical Fractures 
  Shreveport, LA - 1/21/2010
• Cervical Neoplasia in patients with Systemic Lupus Erythematosus. 
  Shreveport, LA. - 1/22/2011
• Treating Advanced Pancreatic Cancer: Finding the Blueprint for Success 
  Shreveport, LA. - 1/29/2012
• Review of RECIST 1.1. 
  Scottsdale, AZ. - 1/23/2014
• Utilizing Cancer Pathways for Drug Development. 
  LSU Health Shreveport, Shreveport, LA - 1/13/2015
• LifeLong Learning Program 
  PebbleCreek. Goodyear, AZ - 1/20/2015
• Pancreatic Cancer: Disease Area Background 
  Chicago, IL - 1/17/2015
• A case of Adenosquamous pancreatic cancer. 
  Scottsdale, AZ. - 1/24/2015
• The Biology of Cancer lecture series 
  HonorHealth Research Institute. - 1/3./2015
• Pancreatic Cancer: Where we are at and where we are going. 
  1/15/2015
• The Molecular Medicine Initiative: Pancreatic Cancer. 
  1/23/2016
• Pancreatic Cancer. 
  University of Arizona, Phoenix Campus, Phoenix, AZ. - 1/7./2016
• Vitamin D and Pancreas Cancer 
  Scottsdale, AZ - 1/19/2016
• Join now to see all

Other

• Symptoms of Impending Gallbladder Perforation and Acute Cholecystitis in a Pancreatic Cancer Patient Masked by Celiac Plexus Block 
  Borazanci E, Luke Dreisbach L, and Ramanathan RK, Gastroenterology & Hepatology: Open Access
  http://medcraveonline.com/GHOA/GHOA-02-00059.pdf
  1/1/2015
• Multiplatform profiling of rare pancreatic carcinoma subtypes to identify potential actionable targets. 
  Borazanci E, Millis SZ, Winkler J, Ramanathan RK, Von Hoff DD., ASCO Meeting. J Clin Oncol
  1/1/2014
• HonorHealth seeks patients for pancreatic cancer 
  Channel 4TV/CBS5
  http://www.azfamily.com/story/32294178/honorhealth-seeks-patients-for-pancreatic-cancer-study
  1/23/2016
• Scottsdale-based study seeks answers on deadly pancreatic cancer. 
  AZ Republic
  http://www.azcentral.com/story/news/local/scottsdale/2016/04/04/scottsdale-based-study-seeks-answers-deadly-pancreatic-cancer/80807292/
  1/4./2016
• Arizona Republic 
  Ask the Expert
  http://www.azcentral.com/story/entertainment/life/health/2016/01/22/researchers-hope-develop-pancreatic-cancer-screening/79154224/?from=global&sessionKey=&autologin=
  1/22/2016
• Interview regarding the Stand Up to Cancer Grant 
  KJZZ
  http://kjzz.org/content/218308/arizona-agencies-picked-international-pancreas-cancer-research-dream-team
  1/12/2015
• Interview regarding clinical trials and pancreatic cancer. 
  Local NPR KJZZ
  http://kjzz.org/content/97425/clinical-trial-new-pancreatic-cancer-drugs-scottsdale
  1/4./2015
• Phoenix interview regarding clinical trials and pancreatic cancer 
  Channel 15
  http://www.abc15.com/news/region-northeast-valley/scottsdale/arizona-cancer-clinical-trial-gives-scottsdale-man-a-second-chance-at-life
  1/9./2015
• Radio interview regarding clinical trials and pancreatic cancer. 
  
  http://ktar.com/22/1796022/Clinical-trial-leads-to-potential-miracle-for-Valley-cancer-patient-
  1/5./2015
• Interview with Jared Dillingham regarding clinical trials and pancreatic cancer 
  KTVK
  http://www.azfamily.com/home/Stage-4-pancreatic-cancer-now-untraceable-in-Phoenix-man-287077571.html
  1/29/2014
• Interview with Jay Crandall regarding FDA approval of Cologuard 
  
  http://www.azfamily.com/news/health/New-Colon-Cancer-test-272634691.html
  1/25/2014
• Join now to see all